StratDeck

Two stocks in Healthcare

AbbVie vs CVS Health: profit, growth, debt and price compared

AbbVie and CVS Health are each stronger on 3 of 6 figures: AbbVie on profit margin, sales growth and price trend; CVS Health on price for its expected profit, dividend and analysts' view.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore AbbVie's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

AbbVie and CVS Health side by side
AbbVieABBVCVS HealthCVS
Net marginStronger: 15.7%2.6%
Revenue growth, past yearStronger: +10.32%+5.37%
Debt to equity—93.3%
Forward P/E17.6×Stronger: 9.3×
Dividend yield2.42%Stronger: 3.27%
AnalystsBuy · 26Stronger: Strong buy · 26
From its 200-day averageStronger: +15.5%−7.3%

Share price over the past year

  • AbbVie+22.3%
  • CVS Health+4.4%

18 Nov 202518 Nov 2026

AbbVie or CVS Health: which is stronger?

  • ABBV

    Which is more profitable?

    AbbVie keeps more of each sale as profit: 15.7% against 2.6%.

  • ABBV

    Which is growing its sales faster?

    AbbVie is growing its sales faster: +10.32% over the past year, against +5.37%.

  • CVS

    Which costs less for the profit it is expected to make?

    CVS Health costs less for the profit it is expected to make: 9.3× its forward earnings, against 17.6×.

  • CVS

    Which pays more in dividends?

    CVS Health pays more back in dividends for what a share costs: 3.27% a year, against 2.42%.

  • CVS

    Which do analysts rate higher?

    Analysts are warmer on CVS Health: Strong buy, against Buy for AbbVie.

  • ABBV

    Which is in the stronger price trend?

    AbbVie's price is in the stronger trend: 15.5% above its 200-day average, against 7.3% below.

What each company does

ABBVAbbVie

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Reports results on 3 February 2027

CVSCVS Health

CVS Health Corporation provides health solutions in the United States.

Reports results on 9 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.